3rd Quarter - Report

AMERICA'S BLOOD CENTERS for AMERICA'S BLOOD CENTERS

Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing, FDA guidance on individual risk assessments for donor deferral, access to blood in hospice and pre-hospital settings

LobbyistCovered position, as disclosed
DIANE RETA CALMUS —
KATE FRY —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); White House Office; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); SENATE

Medical/Disease Research/Clinical Labs MED

Value of Blood/Reimbursement, laboratory developed tests, testing of blood donations for Malaria

LobbyistCovered position, as disclosed
DIANE RETA CALMUS —
KATE FRY —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Disaster Planning/Emergencies DIS

Blood centers disaster preparedness and response activities, cybersecurity

LobbyistCovered position, as disclosed
DIANE RETA CALMUS —
KATE FRY —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.